Biomolecular drug delivery engineers create innovative systems that transport delicate biomolecules—such as proteins, peptides, and nucleic acids—to targeted tissues or cells efficiently and safely. These biomolecules often face significant challenges, including instability, enzymatic degradation, and poor cellular uptake, which can hinder their therapeutic effectiveness. To overcome these obstacles, these engineers design and optimize delivery platforms like nanoparticles, liposomes, and polymeric carriers that protect the biomolecules, control their release, and enhance targeting capabilities. Their work is vital in advancing treatments for complex diseases such as cancer, genetic disorders, and autoimmune conditions, where precision and efficacy are critical.
Biomolecular drug delivery engineers perform extensive evaluations to ensure biocompatibility, optimize pharmacokinetics, and minimize side effects. They collaborate closely with molecular biologists, pharmacologists, and clinicians to translate laboratory discoveries into effective clinical therapies. As personalized medicine and biotechnology continue to grow, these engineers play a pivotal role in tailoring therapies to individual patient needs and overcoming biological barriers. Their ongoing innovations are essential to expanding the therapeutic potential of biomolecules and improving patient outcomes. Through integrating engineering principles with biological insights, they develop solutions that are both scientifically advanced and clinically practical. Ultimately, biomolecular drug delivery engineers help bridge the gap between scientific research and practical medicine, driving forward the future of precision therapeutics.
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, InMedStar and Biona, Russian Federation
Title : Precision diagnostics: Effectiveness of innovative imaging technologies for early detection of lung cancers
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Design and characterization of gum arabic buccal films for protein drug delivery
Krisztian Pamlenyi, University of Szeged, Hungary
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand